Overview
Insulin resistance is a metabolic condition in which the body’s cells respond poorly to insulin, requiring higher levels of insulin to keep blood sugar within a normal range. Over time, this compensatory state strains the pancreas and increases the risk of prediabetes, type 2 diabetes, fatty liver disease, and cardiovascular disease. In Indian and South Asian populations, insulin resistance often develops years before blood sugar levels become abnormal and may occur even in individuals who are not visibly overweight.
What insulin normally does
Insulin is a hormone produced by the pancreas that allows glucose (sugar) from the bloodstream to enter cells, where it is used for energy or stored for later use.
After a meal:
- Blood glucose rises
- The pancreas releases insulin
- Cells respond to insulin and absorb glucose
- Blood glucose levels return to baseline
This process keeps energy supply stable and prevents prolonged high blood sugar.
What happens in insulin resistance
In insulin resistance, cells—particularly in muscle, liver, and fat tissue—become less responsive to insulin’s signal.
As a result:
- The pancreas releases more insulin to compensate
- Blood sugar may remain normal initially
- Insulin levels stay chronically elevated (hyperinsulinemia)
This stage can persist silently for many years before blood sugar levels rise.
Why insulin resistance often goes undetected
Insulin resistance is frequently missed because standard screening tests focus on glucose, not insulin.
Common reasons it remains undiagnosed include:
- Normal fasting glucose despite high insulin levels
- Normal HbA1c in early stages
- Absence of obvious symptoms
- Overreliance on body weight or BMI as risk markers
By the time glucose levels rise, insulin resistance is often well-established.
Causes of insulin resistance
Biological factors
- Genetic predisposition (strong in South Asian populations)
- Visceral (abdominal) fat accumulation
- Reduced muscle insulin sensitivity
- Hormonal changes (e.g., PCOS)
Lifestyle factors
- High intake of refined carbohydrates
- Sedentary behavior
- Chronic sleep deprivation
- Persistent psychological stress
India-specific contributors
- High-carbohydrate vegetarian diets with low protein
- Central obesity at lower body weight
- Early metabolic dysfunction despite “normal” BMI
- Family history of diabetes at young ages
Symptoms of insulin resistance
Insulin resistance may cause no obvious symptoms initially. When present, symptoms are often nonspecific.
Possible signs include:
- Persistent fatigue or brain fog
- Difficulty losing abdominal fat
- Frequent hunger or sugar cravings
- Post-meal drowsiness
- Darkened skin patches (acanthosis nigricans)
- Irregular menstrual cycles (in women)
These symptoms are often attributed to lifestyle or stress rather than underlying metabolic dysfunction.
Conditions linked to insulin resistance
Insulin resistance is not an isolated disorder. It underlies or contributes to several common conditions:
- Prediabetes
- Type 2 diabetes
- Fatty liver disease (NAFLD)
- Polycystic ovary syndrome (PCOS)
- Metabolic obesity
- Cardiovascular disease
Because it precedes these conditions, insulin resistance is often the earliest detectable metabolic abnormality.
How insulin resistance is diagnosed
Common tests
- Fasting blood glucose
- HbA1c (average blood sugar over ~3 months)
These tests may remain normal in early insulin resistance.
More informative markers
- Fasting insulin levels
- HOMA-IR (calculated from fasting glucose and insulin)
- Triglyceride-to-HDL ratio (indirect marker)
There is no universally agreed “normal” fasting insulin range, but persistently elevated insulin suggests reduced insulin sensitivity.
Can insulin resistance be reversed?
Insulin resistance is not necessarily permanent, especially when detected early.
Improvement typically involves:
- Reducing insulin demand
- Improving muscle insulin sensitivity
- Addressing visceral fat accumulation
- Optimizing sleep and stress
The specific approach varies by individual and should be guided by medical professionals when needed.
When to see a doctor
Medical evaluation is advisable if:
- Blood sugar is rising despite lifestyle changes
- There is a strong family history of diabetes
- Symptoms such as unexplained fatigue or abdominal weight gain persist
- PCOS, fatty liver, or metabolic abnormalities are present
Early assessment can help prevent progression to overt diabetes.
Key takeaways
- Insulin resistance often develops long before diabetes
- Blood sugar tests alone may miss early disease
- Indians are at higher risk at lower body weight
- Early identification allows meaningful intervention
Editorial note
Reviewed for medical accuracy. Educational content only. This article is for educational purposes only and does not replace professional medical advice.
References
- Reaven GM. Insulin resistance and its consequences: non–insulin-dependent diabetes mellitus and coronary heart disease. Diabetes Care. 1993;16(1):159–168. doi:10.2337/diacare.16.1.159
- DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–194. doi:10.2337/diacare.14.3.173
- Ferrannini E, Natali A, Bell P, et al. Insulin resistance and hypersecretion in obesity. J Clin Invest. 1997;100(5):1166–1173. doi:10.1172/JCI119628
- Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes. Lancet. 2009;373(9682):2215–2221. doi:10.1016/S0140-6736(09)60619-X
- Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104(6):787–794. doi:10.1172/JCI7231
- Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V. Type 2 diabetes in South Asians: similarities and differences with white Caucasian populations. Diabetes Care. 2014;37(6):1643–1650. doi:10.2337/dc13-2394
- Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrient. 2013;5(7):2708–2733. doi:10.3390/nu5072708
- Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr. 2004;134(1):205–210. doi:10.1093/jn/134.1.205
- Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171–176. doi:10.1172/JCI10583
- Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852–871. doi:10.1016/j.cell.2012.02.017
- Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
- McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96(3):399–404. doi:10.1016/j.amjcard.2005.03.085
- Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease. Hepatology. 2005;42(4):987–994. doi:10.1002/hep.20878
- Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800. doi:10.1210/edrv.18.6.0318
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi:10.1056/NEJMoa012512
- Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–2223. doi:10.1152/physrev.00063.2017